Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FSZ55
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency (DLA) on September 2, 2025, for Entyvio 300 mg vials with a ceiling value of $49.4k and firm fixed-price terms. The delivery order is set to be completed by September 23, 2025, with performance taking place at the contractor's Park Ridge facility. This award carries no set-aside designation, demonstrating the company's competitive positioning in the federal pharmaceutical procurement market despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs at Department of Defense healthcare facilities. Entyvio, a gastrointestinal biologic medication, falls within the company's established portfolio of specialty pharmaceutical products supporting military health systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FSZ55?
SPE2DB25FSZ55 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FSZ55 worth?
The government has obligated $49,449 on SPE2DB25FSZ55.
Is contract SPE2DB25FSZ55 an order under another contract?
Yes. SPE2DB25FSZ55 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ55 competed?
The extent of competition for SPE2DB25FSZ55 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award